checkAd

     150  0 Kommentare Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

    COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Paul Chaplin
    2. Reason for the notification
    a) Position/status

     
    President and Chief Executive Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 88,325
    d) Aggregated information
    • Aggregated volume
    • Price
     

    88,325
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue


    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Henrik Juuel
    2. Reason for the notification
    a) Position/status

     
    Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 38,162
    d) Aggregated information
    • Aggregated volume
    • Price
     

    38,162
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue


    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Jean-Christophe May
    2. Reason for the notification
    a) Position/status

     
    Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 34,263
    d) Aggregated information
    • Aggregated volume
    • Price
     

    34,263
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue


    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Laurence De Moerlooze
    2. Reason for the notification
    a) Position/status

     
    Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 32,934
    d) Aggregated information
    • Aggregated volume
    • Price
     

    32,934
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue


    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Anu Helena Kerns
    2. Reason for the notification
    a) Position/status

     
    Executive Vice President People & Organization of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 22,902
    d) Aggregated information
    • Aggregated volume
    • Price
     

    22,902
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue


    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Russell Thirsk
    2. Reason for the notification
    a) Position/status

     
    Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Warrants


    DK0015998017
    b) Nature of the transaction Grant
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 0.00 32,201
    d) Aggregated information
    • Aggregated volume
    • Price
     

    32,201
    DKK 0.00
    e) Date of the transaction 2022-12-08
    f) Place of the transaction Outside a trading venue

    About Bavarian Nordic
    Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against mpox (monkeypox). The vaccine is also approved in Canada and Europe. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.

    Contacts
    Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
    US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

    Company Announcement no. 44 / 2022

    Attachment





    globenewswire
    0 Follower
    Autor folgen
    Verfasst von globenewswire
    Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or …